North America Capecitabine Market by Manufacturers, Countries, Type and Application, Forecast to 2022

January 2018 | 121 pages | ID: NB76C204BE1EN
GlobalInfoResearch

Abstracts

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.

Scope of the Report:

This report focuses on the Capecitabine in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers

• Roche
• Teva
• Mylan
• Hikma
• Hengrui Medicine
• Cipla
• Reliance Group
• Hetero

Market Segment by Countries, covering

• United States
• Canada
• Mexico

Market Segment by Type, covers

• 500 mg
• 150 mg

Market Segment by Applications, can be divided into

• Breast Cancer
• Colorectal Cancer
• Stomach Cancer

There are 15 Chapters to deeply display the North America Capecitabine market.

Chapter 1, to describe Capecitabine Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Capecitabine, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Capecitabine, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Capecitabine market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Capecitabine Research Findings and Conclusion, Appendix, methodology and data source

Contents

1 MARKET OVERVIEW

1.1 Capecitabine Introduction
1.2 Market Analysis by Type
  1.2.1 500 mg
  1.2.2 150 mg
1.3 Market Analysis by Applications
  1.3.1 Breast Cancer
  1.3.2 Colorectal Cancer
  1.3.3 Stomach Cancer
1.4 Market Analysis by Countries
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 Mexico Status and Prospect (2012-2022)
  1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Roche
  2.1.1 Profile
  2.1.2 Capecitabine Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Roche Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 Roche News
2.2 Teva
  2.2.1 Profile
  2.2.2 Capecitabine Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Teva Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 Teva News
2.3 Mylan
  2.3.1 Profile
  2.3.2 Capecitabine Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Mylan Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.3.4 Business Overview
  2.3.5 Mylan News
2.4 Hikma
  2.4.1 Profile
  2.4.2 Capecitabine Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Hikma Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.4.4 Business Overview
  2.4.5 Hikma News
2.5 Hengrui Medicine
  2.5.1 Profile
  2.5.2 Capecitabine Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 Hengrui Medicine Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.5.4 Business Overview
  2.5.5 Hengrui Medicine News
2.6 Cipla
  2.6.1 Profile
  2.6.2 Capecitabine Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Cipla Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.6.4 Business Overview
  2.6.5 Cipla News
2.7 Reliance Group
  2.7.1 Profile
  2.7.2 Capecitabine Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Reliance Group Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.7.4 Business Overview
  2.7.5 Reliance Group News
2.8 Hetero
  2.8.1 Profile
  2.8.2 Capecitabine Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 Hetero Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.8.4 Business Overview
  2.8.5 Hetero News

3 NORTH AMERICA CAPECITABINE MARKET COMPETITION, BY MANUFACTURER

3.1 North America Capecitabine Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Capecitabine Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Capecitabine Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Capecitabine Manufacturer Market Share
  3.4.2 Top 5 Capecitabine Manufacturer Market Share
3.5 Market Competition Trend

4 NORTH AMERICA CAPECITABINE MARKET ANALYSIS BY COUNTRIES

4.1 North America Capecitabine Sales Market Share by Countries
4.2 North America Capecitabine Sales by Countries (2012-2017)
4.3 North America Capecitabine Revenue (Value) by Countries (2012-2017)

5 NORTH AMERICA MARKET SEGMENTATION CAPECITABINE BY TYPE

5.1 North America Capecitabine Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 North America Capecitabine Sales and Market Share by Type (2012-2017)
  5.1.2 North America Capecitabine Revenue and Market Share by Type (2012-2017)
5.2 500 mg Sales Growth and Price
  5.2.1 North America 500 mg Sales Growth (2012-2017)
  5.2.2 North America 500 mg Price (2012-2017)
5.3 150 mg Sales Growth and Price
  5.3.1 North America 150 mg Sales Growth (2012-2017)
  5.3.2 North America 150 mg Price (2012-2017)

6 NORTH AMERICA MARKET SEGMENTATION CAPECITABINE BY APPLICATION

6.1 North America Capecitabine Sales Market Share by Application (2012-2017)
6.2 Breast Cancer Sales Growth (2012-2017)
6.3 Colorectal Cancer Sales Growth (2012-2017)
6.4 Stomach Cancer Sales Growth (2012-2017)

7 UNITED STATES CAPECITABINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 United States Capecitabine Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Capecitabine Sales and Market Share by Type
7.3 United States Capecitabine Sales by Application (2012-2017)
7.4 United States Capecitabine Sales, Revenue and Market Share by Manufacturer
  7.4.1 United States Capecitabine Sales and Market Share by Manufacturer
  7.4.2 United States Capecitabine Revenue and Market Share by Manufacturer
7.5 United States Capecitabine Export and Import (2012-2017)

8 CANADA CAPECITABINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 Canada Capecitabine Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Capecitabine Sales and Market Share by Type
8.3 Canada Capecitabine Sales by Application (2012-2017)
8.4 Canada Capecitabine Sales, Revenue and Market Share by Manufacturer
  8.4.1 Canada Capecitabine Sales and Market Share by Manufacturer
  8.4.2 Canada Capecitabine Revenue and Market Share by Manufacturer
8.5 Canada Capecitabine Export and Import (2012-2017)

9 MEXICO CAPECITABINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Mexico Capecitabine Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Capecitabine Sales and Market Share by Type
9.3 Mexico Capecitabine Sales by Application (2012-2017)
9.4 Mexico Capecitabine Sales, Revenue and Market Share by Manufacturer
  9.4.1 Mexico Capecitabine Sales and Market Share by Manufacturer
  9.4.2 Mexico Capecitabine Revenue and Market Share by Manufacturer
9.5 Mexico Capecitabine Export and Import (2012-2017)

10 CAPECITABINE MARKET FORECAST (2017-2022)

10.1 North America Capecitabine Sales, Revenue and Growth Rate (2017-2022)
10.2 Capecitabine Market Forecast by Countries (2017-2022)
  10.2.1 United States Capecitabine Forecast (2017-2022)
  10.2.2 Canada Capecitabine Forecast (2017-2022)
  10.2.3 Mexico Capecitabine Forecast (2017-2022)
10.3 Capecitabine Market Forecast by Type (2017-2022)
10.4 Capecitabine Market Forecast by Application (2017-2022)

11 CAPECITABINE MANUFACTURING COST ANALYSIS

11.1 Capecitabine Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Capecitabine

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Capecitabine Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Capecitabine Major Manufacturers in 2016
12.4 Downstream Buyers

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Capecitabine Picture
Table Product Specifications of Capecitabine
Figure North America Sales Market Share of Capecitabine by Types in 2016
Table Types of Capecitabine
Figure 500 mg Picture
Table Major Manufacturers of 500 mg
Figure 150 mg Picture
Table Major Manufacturers of 150 mg
Table North America Capecitabine Sales Market Share by Applications in 2016
Table Applications of Capecitabine
Figure Breast Cancer Picture
Figure Colorectal Cancer Picture
Figure Stomach Cancer Picture
Figure United States Capecitabine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Capecitabine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Capecitabine Revenue (Million USD) and Growth Rate (2012-2022)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Capecitabine Type and Applications
Table Roche Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Capecitabine Type and Applications
Table Teva Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Capecitabine Type and Applications
Table Mylan Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Hikma Basic Information, Manufacturing Base and Competitors
Table Hikma Capecitabine Type and Applications
Table Hikma Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table Hengrui Medicine Capecitabine Type and Applications
Table Hengrui Medicine Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Capecitabine Type and Applications
Table Cipla Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Reliance Group Basic Information, Manufacturing Base and Competitors
Table Reliance Group Capecitabine Type and Applications
Table Reliance Group Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Hetero Basic Information, Manufacturing Base and Competitors
Table Hetero Capecitabine Type and Applications
Table Hetero Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Capecitabine Sales by Manufacturer (2016-2017)
Figure North America Capecitabine Sales Market Share by Manufacturer in 2016
Figure North America Capecitabine Sales Market Share by Manufacturer in 2017
Table North America Capecitabine Revenue by Manufacturer (2016-2017)
Figure North America Capecitabine Revenue Market Share by Manufacturer in 2016
Figure North America Capecitabine Revenue Market Share by Manufacturer in 2017
Table North America Capecitabine Price by Manufacturers (2016-2017)
Figure Top 3 Capecitabine Manufacturer Market Share in 2016
Figure Top 3 Capecitabine Manufacturer Market Share in 2017
Figure Top 5 Capecitabine Manufacturer Market Share in 2016
Figure Top 5 Capecitabine Manufacturer Market Share in 2017
Figure North America Capecitabine Sales and Growth (2012-2017)
Table North America Capecitabine Sales by Countries (2012-2017)
Table North America Capecitabine Sales Market Share by Countries (2012-2017)
Figure North America 2012 Capecitabine Sales Market Share by Countries
Figure North America 2016 Capecitabine Sales Market Share by Countries
Figure North America Capecitabine Revenue and Growth (2012-2017)
Table North America Capecitabine Revenue by Countries (2012-2017)
Table North America Capecitabine Revenue Market Share by Countries (2012-2017)
Table North America 2012 Capecitabine Revenue Market Share by Countries
Table North America 2016 Capecitabine Revenue Market Share by Countries
Table North America Capecitabine Sales by Type (2012-2017)
Table North America Capecitabine Sales Share by Type (2012-2017)
Table North America Capecitabine Revenue by Type (2012-2017)
Table North America Capecitabine Revenue Share by Type (2012-2017)
Figure North America 500 mg Sales Growth (2012-2017)
Figure North America 500 mg Price (2012-2017)
Figure North America 150 mg Sales Growth (2012-2017)
Figure North America 150 mg Price (2012-2017)
Table North America Capecitabine Sales by Application (2012-2017)
Table North America Capecitabine Sales Share by Application (2012-2017)
Figure North America Breast Cancer Sales Growth (2012-2017)
Figure North America Colorectal Cancer Sales Growth (2012-2017)
Figure North America Stomach Cancer Sales Growth (2012-2017)
Figure United States Capecitabine Revenue and Growth (2012-2017)
Figure United States Capecitabine Sales and Growth (2012-2017)
Table United States Capecitabine Sales by Type (2012-2017)
Table United States Capecitabine Sales Market Share by Type (2012-2017)
Table United States Capecitabine Sales by Application (2012-2017)
Table United States Capecitabine Sales Market Share by Application (2012-2017)
Table United States Capecitabine Sales by Manufacturer (2016-2017)
Figure United States Capecitabine Sales Market Share by Manufacturer in 2016
Figure United States Capecitabine Sales Market Share by Manufacturer in 2017
Table United States Capecitabine Revenue by Manufacturer (2016-2017)
Figure United States Capecitabine Revenue Market Share by Manufacturer in 2016
Figure United States Capecitabine Revenue Market Share by Manufacturer in 2017
Table United States Capecitabine Export and Import (2012-2017)
Figure Canada Capecitabine Revenue and Growth (2012-2017)
Figure Canada Capecitabine Sales and Growth (2012-2017)
Table Canada Capecitabine Sales by Type (2012-2017)
Table Canada Capecitabine Sales Market Share by Type (2012-2017)
Table Canada Capecitabine Sales by Application (2012-2017)
Table Canada Capecitabine Sales Market Share by Application (2012-2017)
Table Canada Capecitabine Sales by Manufacturer (2016-2017)
Figure Canada Capecitabine Sales Market Share by Manufacturer in 2016
Figure Canada Capecitabine Sales Market Share by Manufacturer in 2017
Table Canada Capecitabine Revenue by Manufacturer (2016-2017)
Figure Canada Capecitabine Revenue Market Share by Manufacturer in 2016
Figure Canada Capecitabine Revenue Market Share by Manufacturer in 2017
Table Canada Capecitabine Export and Import (2012-2017)
Figure Mexico Capecitabine Revenue and Growth (2012-2017)
Figure Mexico Capecitabine Sales and Growth (2012-2017)
Table Mexico Capecitabine Sales by Type (2012-2017)
Table Mexico Capecitabine Sales Market Share by Type (2012-2017)
Table Mexico Capecitabine Sales by Application (2012-2017)
Table Mexico Capecitabine Sales Market Share by Application (2012-2017)
Table Mexico Capecitabine Sales by Manufacturer (2016-2017)
Figure Mexico Capecitabine Sales Market Share by Manufacturer in 2016
Figure Mexico Capecitabine Sales Market Share by Manufacturer in 2017
Table Mexico Capecitabine Revenue by Manufacturer (2016-2017)
Figure Mexico Capecitabine Revenue Market Share by Manufacturer in 2016
Figure Mexico Capecitabine Revenue Market Share by Manufacturer in 2017
Table Mexico Capecitabine Export and Import (2012-2017)
Figure North America Capecitabine Sales, Revenue and Growth Rate (2017-2022)
Table North America Capecitabine Sales Forecast by Countries (2017-2022)
Table North America Capecitabine Market Share Forecast by Countries (2017-2022)
Figure United States Capecitabine Sales Forecast (2017-2022)
Figure Canada Capecitabine Sales Forecast (2017-2022)
Figure Mexico Capecitabine Sales Forecast (2017-2022)
Table North America Capecitabine Sales Forecast by Type (2017-2022)
Table North America Capecitabine Market Share Forecast by Type (2017-2022)
Table North America Capecitabine Sales Forecast by Application (2017-2022)
Table North America Capecitabine Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Capecitabine
Figure Manufacturing Process Analysis of Capecitabine
Figure Capecitabine Industrial Chain Analysis
Table Raw Materials Sources of Capecitabine Major Manufacturers in 2016
Table Major Buyers of Capecitabine
Table Distributors/Traders/ Dealers List